Bacillus Calmette-Guerin strain may not effect recurrence-free survival when used intravesically with interferon-alpha2b for non–muscle-invasive bladder cancer

Overview of attention for article published in Urologic Oncology, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

wikipedia: 1 Wikipedia page

guideline: 2 clinical guideline sources

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update

Clinical guideline published by European Association of Urology (EAU) on 17 Aug 2024

The European Association of Urology (EAU) is a leading authority in urological practice, research, and education across Europe. It aims to enhance urological care through guidelines, educational events, and resources, empowering professionals to provide optimal patient care.

NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.

Clinical guideline published by National Comprehensive Cancer Network (NCCN) on 01 Aug 2022

The National Comprehensive Cancer Network (NCCN) is a non-profit alliance of 33 leading cancer centers focused on enhancing patient care, research, and education. It aims to improve cancer care quality and accessibility through comprehensive guidelines and resources for clinicians and patients.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.